Lmr Partners LLP Capricor Therapeutics, Inc. Call Options Transaction History
Lmr Partners LLP
- $8.3 Billion
- Q1 2025
Call Options
1 transactions
Others Institutions Holding CAPR
# of Institutions
141Shares Held
17.2MCall Options Held
1.51MPut Options Held
1.02M-
Vanguard Group Inc Valley Forge, PA2.26MShares$18.4 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$18.3 Million0.12% of portfolio
-
State Street Corp Boston, MA1.84MShares$15 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$13.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA901KShares$7.34 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $198M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...